UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 265

Sortiert nach

Metabolic stress in insulin’s target cells leads to ROS accumulation – A hypothetical common pathway causing insulin resistance

FEBS letters, 2007-07, Vol.581 (19), p.3734-3742

Eriksson, Jan W.

2007

Link zum Volltext

Verfügbarkeit prüfen

Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes

Diabetologia, 2021-03, Vol.64 (3), p.641-655

2021

Link zum Volltext

Verfügbarkeit prüfen

Quality of life of type 2 diabetes mellitus patients in Ramallah and al-Bireh Governorate–Palestine: a part of the Palestinian diabetes complications and control study (PDCCS)

Quality of life research, 2021-05, Vol.30 (5), p.1407-1416

2021

Link zum Volltext

Verfügbarkeit prüfen

Metformin as an anti-inflammatory agent: a short review

Journal of endocrinology, 2021-09, Vol.251 (2), p.R11-R22

2021

Link zum Volltext

Verfügbarkeit prüfen

Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data

Cardiovascular diabetology, 2022-12, Vol.21 (1), p.282-282, Article 282

2022

Link zum Volltext

Verfügbarkeit prüfen

Cardiomyocyte-specific Loss of Diacylglycerol Acyltransferase 1 (DGAT1) Reproduces the Abnormalities in Lipids Found in Severe Heart Failure

The Journal of biological chemistry, 2014-10, Vol.289 (43), p.29881-29891

2014

Link zum Volltext

Verfügbarkeit prüfen

Fatty Acid Proportions in Plasma Cholesterol Esters and Phospholipids Are Positively Correlated in Various Swedish Populations

The Journal of nutrition, 2017-11, Vol.147 (11), p.2118-2125

2017

Link zum Volltext

Verfügbarkeit prüfen

Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus

Nutrition, metabolism, and cardiovascular diseases, 2008-09, Vol.18 (7), p.503-510

2008

Link zum Volltext

Verfügbarkeit prüfen

Novel pancreatic beta cell-specific proteins: Antibody-based proteomics for identification of new biomarker candidates

Journal of proteomics, 2012-05, Vol.75 (9), p.2611-2620

2012

Link zum Volltext

Verfügbarkeit prüfen

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study

Diabetologia, 2018-09, Vol.61 (9), p.1923-1934

2018

Link zum Volltext

Verfügbarkeit prüfen

CABLES1 expression is reduced in human subcutaneous adipose tissue in obesity and type 2 diabetes but may not directly impact adipocyte glucose and lipid metabolism

Adipocyte, 2023-12, Vol.12 (1), p.2242997-2242997

2023

Link zum Volltext

Verfügbarkeit prüfen

Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity?

Cardiovascular diabetology, 2016-06, Vol.15 (1), p.91-91, Article 91

2016

Link zum Volltext

Verfügbarkeit prüfen

Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner

Upsala journal of medical sciences, 2019-08, Vol.124 (3), p.158-167

2019

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes

Diabetes care, 2002-05, Vol.25 (5), p.869-875

2002

Link zum Volltext

Verfügbarkeit prüfen

Microdialysis and proteomics of subcutaneous interstitial fluid reveals increased galectin-1 in type 2 diabetes patients

Metabolism, clinical and experimental, 2016-07, Vol.65 (7), p.998-1006

2016

Link zum Volltext

Verfügbarkeit prüfen

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study

Diabetes, obesity & metabolism, 2019-05, Vol.21 (5), p.1136-1145

2019

Link zum Volltext

Verfügbarkeit prüfen

Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?

Diabetologia, 2022-10, Vol.65 (10), p.1575-1586

2022

Link zum Volltext

Verfügbarkeit prüfen

Regulation of the Cortisol Axis, Glucagon, and Growth Hormone by Glucose Is Altered in Prediabetes and Type 2 Diabetes

The journal of clinical endocrinology and metabolism, 2024-01, Vol.109 (2), p.e675-e688

2024

Link zum Volltext

Verfügbarkeit prüfen

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study

Diabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.344-351

2018

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis

The lancet. Diabetes & endocrinology, 2017-09, Vol.5 (9), p.709-717

2017

Link zum Volltext

Verfügbarkeit prüfen

Increased OCT3 Expression in Adipose Tissue With Aging: Implications for Catecholamine and Lipid Turnover and Insulin Resistance in Women

Endocrinology (Philadelphia), 2023-11, Vol.165 (1)

2023

Link zum Volltext

Verfügbarkeit prüfen

Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013

Diabetologia, 2016-08, Vol.59 (8), p.1692-1701

2016

Link zum Volltext

Verfügbarkeit prüfen

Glucose-dependent inflammatory responses in obese compared to lean individuals

Endocrine, 2023-09, Vol.81 (3), p.464-476

2023

Link zum Volltext

Verfügbarkeit prüfen

Insulin resistance in diabetic nephropathy - cause or consequence?

Diabetes/metabolism research and reviews, 2006-09, Vol.22 (5), p.401-410

2006

Link zum Volltext

Verfügbarkeit prüfen

Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes

Molecular and cellular endocrinology, 2020-03, Vol.503, p.110696, Article 110696

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 265

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(249)
Mit Volltextzugriff
(228)

Publikationsform

Artikel
(264)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolic stress in insulin’s target cells leads to ROS accumulation – A hypothetical common pathway causing insulin resistance

Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes

Quality of life of type 2 diabetes mellitus patients in Ramallah and al-Bireh Governorate–Palestine: a part of the Palestinian diabetes complications and control study (PDCCS)

Metformin as an anti-inflammatory agent: a short review

Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data

Cardiomyocyte-specific Loss of Diacylglycerol Acyltransferase 1 (DGAT1) Reproduces the Abnormalities in Lipids Found in Severe Heart Failure

Fatty Acid Proportions in Plasma Cholesterol Esters and Phospholipids Are Positively Correlated in Various Swedish Populations

Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus

Novel pancreatic beta cell-specific proteins: Antibody-based proteomics for identification of new biomarker candidates

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study

CABLES1 expression is reduced in human subcutaneous adipose tissue in obesity and type 2 diabetes but may not directly impact adipocyte glucose and lipid metabolism

Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity?

Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner

Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes

Microdialysis and proteomics of subcutaneous interstitial fluid reveals increased galectin-1 in type 2 diabetes patients

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study

Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?

Regulation of the Cortisol Axis, Glucagon, and Growth Hormone by Glucose Is Altered in Prediabetes and Type 2 Diabetes

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis

Increased OCT3 Expression in Adipose Tissue With Aging: Implications for Catecholamine and Lipid Turnover and Insulin Resistance in Women

Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013

Glucose-dependent inflammatory responses in obese compared to lean individuals

Insulin resistance in diabetic nephropathy - cause or consequence?

Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes

Aktive Filter

Suchergebnisse filtern